Clinical Trials
5 trialsNCT01290692 2023-07-03
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
TVAX Biomedical
Phase 2 Completed
NCT01081223 2023-06-01
Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
TVAX Biomedical
Phase 1/2 Completed
NCT01684241 2020-01-18
MERIT
BioNTech SE
Phase 1 Completed
NCT02035956 2020-01-18
IVAC MUTANOME Phase I Clinical Trial
BioNTech SE
Phase 1 Completed
NCT01525017 2015-10-12
A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer
Mendus
Phase 1 Completed